EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The utility of C‐reactive protein in neonatal early‐onset sepsis screening: A territory‐wide cohort analysis

Xuelian Wang, Hoi Ying Sharon Lau, Hiu Ying Peggy Chan, Po Gee Genevieve Fung, Hugh Simon Lam

Pediatric Investigation · 2025-12 · 9 (4) · 337-346

DOI: 10.1002/ped4.70025 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Importance C‐reactive protein (CRP) is a commonly used biomarker for sepsis. Objective This study aimed to evaluate CRP's diagnostic performance to detect neonatal early‐onset sepsis (EOS), while accounting for both gestational and postnatal age. Methods We conducted a multicenter retrospective study of neonates born from January 2006 to December 2017 in public hospitals in Hong Kong. Neonates who had CRP tested within 72 h of birth, prior to antibiotics initiation, were included. CRP values were analyzed by gestational age and time after birth. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curves, sensitivity, specificity, predictive values, and likelihood ratios (LRs). Results Among 100 327 tested neonates, 448 developed culture‐confirmed EOS, and 34 had meningitis. In uninfected neonates, CRP concentrations rose naturally after 8 h of life, peaking at 24–32 h, with higher values in term neonates at 24–48 h (median 6.2 mg/L, interquartile range 2.9–14.3). Diagnostic performance was better in preterm neonates (e.g., the area under the ROC curve after 4 h of life: 0.88 in 12.0 mg/L was associated with increased risk of meningitis. Interpretation CRP is not recommended for EOS screening in term neonates, but it may be considered for assessing the risk of EOS in preterm neonates. Interpretation must account for gestational and postnatal age.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →